Search

everythinglearnresearchcommunity

for

Search:↓

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Cholecystokinin may help reduce skin inflammation in psoriasis.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

PRP treatment reduces inflammation and increases interleukin-10 in alopecia areata patients.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Certain bacteria can enhance skin regeneration.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Tph cells are linked to the severity of systemic lupus erythematosus.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Skin bacteria, specifically Streptococcus and Staphylococcus, help in hair regrowth after skin injury and speed up wound healing.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Using 5% minoxidil foam twice daily can help regrow hair, especially in younger men aged 20-30.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.